{"nct_id":"NCT01925209","title":"Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2013-09-26","start_date_type":"ACTUAL","primary_completion_date":"2016-01-06","primary_completion_date_type":"ACTUAL","completion_date":"2016-01-06","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["NVS"]}